Detalles de la búsqueda
1.
The dual inhibitor of the phosphoinositol-3 and PIM kinases, IBL-202, is effective against chronic lymphocytic leukaemia cells under conditions that mimic the hypoxic tumour microenvironment.
Br J Haematol
; 182(5): 654-669, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29978459
2.
MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment.
Br J Haematol
; 182(3): 360-372, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29767411
3.
Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
J Neurooncol
; 131(2): 233-244, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27770278
4.
The effect of HYPE knock-out on the AMPylome of human OSU-CLL leukemia cells.
Leuk Lymphoma
; 65(2): 242-249, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37933638
5.
The CIpP activator, TR-57, is highly effective as a single agent and in combination with venetoclax against CLL cells in vitro.
Leuk Lymphoma
; 65(5): 585-597, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38227293
6.
Hsp90 Inhibitor SNX-7081 dysregulates proteins involved with DNA repair and replication and the cell cycle in human chronic lymphocytic leukemia (CLL) cells.
J Proteome Res
; 12(4): 1710-22, 2013 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23458665
7.
Profiles of surface mosaics on chronic lymphocytic leukemias distinguish stable and progressive subtypes.
J Pharm Pharm Sci
; 16(2): 231-7, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23958192
8.
Combination of High-Resolution Structures for the B Cell Receptor and Co-Receptors Provides an Understanding of Their Interactions with Therapeutic Antibodies.
Cancers (Basel)
; 15(11)2023 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37296844
9.
Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL.
J Proteome Res
; 11(2): 1240-50, 2012 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-22133146
10.
Fludarabine and cladribine induce changes in surface proteins on human B-lymphoid cell lines involved with apoptosis, cell survival, and antitumor immunity.
J Proteome Res
; 11(9): 4436-48, 2012 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-22839105
11.
iTRAQ-based proteomic profiling of breast cancer cell response to doxorubicin and TRAIL.
J Proteome Res
; 11(7): 3561-72, 2012 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-22587632
12.
Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray.
Liver Int
; 32(10): 1527-34, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22863037
13.
Adenylated proteins in mouse B16-F10 melanoma cells cluster in functional categories: a new paradigm for cellular regulation?
Nucleosides Nucleotides Nucleic Acids
; 41(3): 255-263, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34738868
14.
Fludarabine nucleoside induces major changes in the p53 interactome in human B-lymphoid cancer cell lines.
Nucleosides Nucleotides Nucleic Acids
; 41(3): 314-320, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34886743
15.
Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma.
J Proteome Res
; 10(3): 1030-42, 2011 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-21182289
16.
The ClpP activator ONC-212 (TR-31) inhibits BCL2 and B-cell receptor signaling in CLL.
EJHaem
; 2(1): 81-93, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35846080
17.
Cell surface markers in colorectal cancer prognosis.
Int J Mol Sci
; 12(1): 78-113, 2010 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-21339979
18.
Therapeutic approaches and drug-resistance in chronic lymphocytic leukaemia.
Cancer Drug Resist
; 3(3): 532-549, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-35582439
19.
IBL-202 is synergistic with venetoclax in CLL under in vitro conditions that mimic the tumor microenvironment.
Blood Adv
; 4(20): 5093-5106, 2020 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085757
20.
Dual inhibition of MEK1/2 and AKT by binimetinib and MK2206 induces apoptosis of chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment.
Leuk Lymphoma
; 60(7): 1632-1643, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30648436